EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Necrotizing Soft Tissue Infections

James McDermott, Lillian S Kao, Jessica A Keeley, Areg Grigorian, Angela Neville, Christian de Virgilio

JAMA Surgery · 01.11.2024 · 159 (11) · 1308

DOI: 10.1001/jamasurg.2024.3365 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JAMA Surgery, erschienen am 01.11.2024. Verfasst von James McDermott und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Stanford University, Stanford, California. Hauptthemen laut MEDLINE: Soft Tissue Infections, Debridement, Anti-Bacterial Agents. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Necrotizing soft tissue infections (NSTIs) are severe life- and limb-threatening infections with high rates of morbidity and mortality. Unfortunately, there has been minimal improvement in outcomes over time. Observations NSTIs are characterized by their heterogeneity in microbiology, risk factors, and anatomical involvement. They often present with nonspecific symptoms, leading to a high rate of delayed diagnosis. Laboratory values and imaging help increase suspicion for NSTI, though ultimately, the diagnosis is clinical. Surgical exploration is warranted when there is high suspicion for NSTI, even if the diagnosis is uncertain. Thus, it is acceptable to have a certain rate of negative exploration. Immediate empirical broad-spectrum antibiotics, further tailored based on tissue culture results, are essential and should be continued at least until surgical debridement is complete and the patient shows signs of clinical improvement. Additional research is needed to determine optimal antibiotic duration. Early surgical debridement is crucial for improved outcomes and should be performed as soon as possible, ideally within 6 hours of presentation. Subsequent debridements should be performed every 12 to 24 hours until the patient is showing signs of clinical improvement and there is no additional necrotic tissue within the wound. There are insufficient data to support the routine use of adjunct treatments such as hyperbaric oxygen therapy and intravenous immunoglobulin. However, clinicians should be aware of multiple ongoing efforts to develop more robust diagnostic and treatment strategies. Conclusions and Relevance Given the poor outcomes associated with NSTIs, a review of clinically relevant evidence and guidelines is warranted. This review discusses diagnostic and treatment approaches to NSTI while highlighting future directions and promising developments in NSTI management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Soft Tissue InfectionsDebridementAnti-Bacterial AgentsHumansNecrosisFasciitis, NecrotizingHyperbaric Oxygenation

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Surgery, Stanford University, Stanford, California.
  • Department of Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston.
  • Department of Surgery, Harbor-UCLA Medical Center, Torrance, California.
  • Department of Surgery, Division of Trauma, Burns, and Surgical Critical Care, University of California, Irvine.

Zitieren

APA

McDermott, J., Kao, L. S., Keeley, J. A., Grigorian, A., Neville, A., & de Virgilio, C. (2024). Necrotizing Soft Tissue Infections. JAMA Surgery, 159(11), 1308. https://doi.org/10.1001/jamasurg.2024.3365

Vancouver

McDermott J, Kao LS, Keeley JA, Grigorian A, Neville A, de Virgilio C. Necrotizing Soft Tissue Infections. JAMA Surgery. 2024;159(11):1308. doi:10.1001/jamasurg.2024.3365

BibTeX
@article{McDermott2024,
  author = {McDermott, James and Kao, Lillian S and Keeley, Jessica A and Grigorian, Areg and Neville, Angela and de Virgilio, Christian},
  title = {Necrotizing Soft Tissue Infections},
  journal = {JAMA Surgery},
  year = {2024},
  volume = {159},
  number = {11},
  pages = {1308},
  doi = {10.1001/jamasurg.2024.3365}
}
Kostenlos starten →